Skip to content

Multi-center Study on Clinical Diagnosis and Treatment of Meibomian Gland Dysfunction (The Evaluation of Ocular Surface and Meibomian Gland Condition after Rafractive Surgery)

Multi-center Study on Clinical Diagnosis and Treatment of Meibomian Gland Dysfunction (The Evaluation of Ocular Surface and Meibomian Gland Condition after Rafractive Surgery)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-17010979
Enrollment
Unknown
Registered
2017-03-25
Start date
2017-04-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Meibomian Gland Disfunction

Interventions

Case series:Rafractive Surgery

Sponsors

Eye and ENT Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age>=18 years old male and female; 2. Received SMILE OR FS-LASIK surgery; 3. No severe Cardia-cerebrovascular Disease.

Exclusion criteria

Exclusion criteria: 1. One of these abnormal ocular surface: such as trachoma, gemphigoid, chemical injury, thermal injury, radiation injury and so on; 2. Abnormal eyelid(such as entropion,ectropion,tumor,edema,spasm of eyelid, hypophasis or lagophthalmus, serious trichiasis and serious ptosis which can affect function of eyelid of any eyes; 3. Pregnant and lactant women.

Design outcomes

Primary

MeasureTime frame
Lipid Layer Thickness and Partial Blink Rate;Meibomian Gland Function Evaluation;Meibomian Gland Function Evaluation;Meibomian Gland Structure IR Imaging;

Secondary

MeasureTime frame
Ocular surface disease index (OSDI);Standard Patient Evaluation of Eye Dryness(SPEED);vision;intraocular pressure;Anterior Segment OCT;Ocular surface Oxford staining;Tear Break-up Time(TBUT);Schirmer I test;

Countries

China

Contacts

Public ContactXingtao Zhou

Eye and ENT Hospital of Fudan University

xingtaozhou@163.com+86 13816880725

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026